Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study

Introduction: Angiotensin-converting enzyme inhibitor (ACEI) and angiotensin II receptor blockers (ARBs) are taken as the first treatment option for hypertensive patients. The various global trials have suggested that ACEIs and ARBs may increase risk of lung cancer; however, the results are contradi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Pardeep, Kumar, Vinod, Murlidhar, Manish, Fatima, Aliya, Jahangir, Maha, Khalid, Dua, Memon, Muhammad Khizar, Memon, Sidra, Kumar, Besham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168993/
https://www.ncbi.nlm.nih.gov/pubmed/34094750
http://dx.doi.org/10.7759/cureus.14788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168993/
https://www.ncbi.nlm.nih.gov/pubmed/34094750
http://dx.doi.org/10.7759/cureus.14788

Ejemplares similares